Effects of liposomal bupivacaine (LB) and provider experience with LB on service utilization, clinical outcomes, and Medicare expenditures among fee-for-service (FFS) beneficiaries
Use of LB and provider LB use rate are associated with improved patient clinical, service utilization, and expenditure outcomes.
Authors
- Al Dobson (ORCID: https://orcid.org/0000-0003-1942-3612)
- Seung Kim (ORCID: https://orcid.org/0000-0001-7783-8432)
- Steven Heath
- Michael Beins (ORCID: https://orcid.org/0009-0006-8045-9293)
- Sung Young Kim (ORCID: https://orcid.org/0000-0003-4702-8265)
- Sarmistha Pal (ORCID: https://orcid.org/0000-0003-3813-2108)
- Richa Zirath
Institutions
- Engineering Associates (United States) (US)
- Applied Research Associates (NZ)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1080/13696998.2025.2510814
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00